NG
ADPT icon

Norden Group’s Adaptive Biotechnologies ADPT Stock Holding History

Norden Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Buy
11,152
+1,122
+11% +$17.2K 0.02% 604
2026
Q1 		$139K Buy
+10,030
New +$160K 0.01% 603

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norden Group's ADPT Position: Q2 2026 in Review

Norden Group increased its Adaptive Biotechnologies (ADPT) stake by 11% in Q2 2026, buying an estimated $17.2K and bringing the position to 11,152 shares worth $239K. The position accounts for 0.02% of the portfolio, ranked #604.

Norden Group first reported a position in ADPT in Q1 2026 and has held it in 2 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Norden Group held 11,152 shares of Adaptive Biotechnologies worth $239K as of Q2 2026.
  • Norden Group bought 1,122 Adaptive Biotechnologies shares in Q2 2026, an estimated $17.2K.
  • Adaptive Biotechnologies made up 0.02% of Norden Group's portfolio in Q2 2026, its #604 holding.
  • Norden Group first reported a position in Adaptive Biotechnologies in Q1 2026 and has held it in 2 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.